Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PCDH17 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MAGEC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
KCNN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF144A-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DIO1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ASPA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRTAP17-1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KLK6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
SEC61A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HOXA10-HOXA9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
INA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SRC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MMP24 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on